Cartalax 10 mg research-grade lyophilized peptide powder in a glass vial. Cartalax is a synthetic tetrapeptide bioregulator with the sequence Ala-Glu-Asp-Gly (AEDG), structurally related to Epithalon and studied in experimental models of musculoskeletal tissue, telomerase activity and gene-expression regulation.

Research Overview

Cartalax (AEDG tetrapeptide) is used in experimental bioregulator research to investigate musculoskeletal tissue homeostasis, telomerase-related mechanisms and gene-expression profiles in cartilage and bone cells. Studies focus on how short regulatory peptides may influence cellular proliferation, differentiation and stress responses in vitro and in vivo laboratory models, without implying any therapeutic application.

Primary Research Areas

• Cartilage & bone tissue models: Musculoskeletal research exploring extracellular matrix turnover, chondrocyte and osteoblast activity, and structural maintenance of cartilage and bone tissue.
• Telomerase & cellular aging: Experimental systems examining how AEDG-class peptides affect telomerase-associated pathways, cellular senescence markers and longevity-related signaling.
• Gene-expression regulation: In vitro models investigating modulation of gene-expression networks in musculoskeletal and related cell types under various stress and adaptation conditions.